Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Harris & Harris Group Notes Solazyme's Successful Scaling of Renewable Oil Fermentation



Harris & Harris Group Notes Solazyme's Successful Scaling of Renewable Oil
Fermentation

NEW YORK, Dec. 14, 2012 (GLOBE NEWSWIRE) -- Harris & Harris Group, Inc.
(Nasdaq:TINY), an early-stage, active investor in transformative
nanotechnology companies, notes the announcement by Solazyme, Inc., that it
has successfully achieved commercial scale production metrics, exhibited
linear scalability of its process from laboratory scale, and demonstrated the
ability to run at this scale without contamination. The fermentations were
conducted in approximately 500,000-liter vessels, which are about four times
the scale of the vessels in Solazyme's Peoria facility. Solazyme is initially
targeting annual production of 20,000 metric tons of oil starting in early
2014 at the ADM facility, with targeted expansion to 100,000 metric tons. The
scale achieved at ADM's Clifton, Iowa facility is comparable to the
fermentation equipment currently under construction at the Solazyme Bunge
Renewable Oils facility in Brazil. This 100,000 metric ton annual nameplate
capacity facility in Brazil is on schedule to begin operations in the fourth
quarter of 2013. The full press release may be viewed at
http://solazyme.com/media/2012-12-13.

Harris & Harris Group is an investor in publicly traded Solazyme, Inc.

Detailed information about Harris & Harris Group and its holdings can be found
on its website at www.HHVC.com.

This press release may contain statements of a forward-looking nature relating
to future events. These forward-looking statements are subject to the inherent
uncertainties in predicting future results and conditions. These statements
reflect the Company's current beliefs, and a number of important factors could
cause actual results to differ materially from those expressed in this press
release.  Please see the Company's Annual Report on Form 10-K for the fiscal
year ended December 31, 2011, as well as subsequent filings, filed with the
Securities and Exchange Commission for a more detailed discussion of the risks
and uncertainties associated with the Company's business, including, but not
limited to, the risks and uncertainties associated with venture capital
investing and other significant factors that could affect the Company's actual
results. Except as otherwise required by Federal securities laws, the Company
undertakes no obligation to update or revise these forward-looking statements
to reflect new events or uncertainties.  The references to the websites
www.HHVC.com and www.solazyme.com have been provided as a convenience, and the
information contained on such websites is not incorporated by reference into
this press release. Harris & Harris Group is not responsible for the contents
of third party websites.

CONTACT: DOUGLAS W. JAMISON
         TEL. NO. (212) 582-0900
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement